NZ eases access to mental health, addiction supportNew Zealand’s Ministry of Health has officially launched an online portal for accessing the services provided by the Access and Choice programme.
The said website puts all Access…
South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration’s 510(k) clearance for its latest AI-powered analysis software for screening lung nodules.The company develops AI imaging solutions for diagnosing various chest…
Continue Reading
Epstein-Barr is among the most common viruses, but no vaccines are available to prevent its infection. Merck is joining the pursuit for a vaccine by striking a deal with Opko Health, paying $50 million…
Continue Reading
Microsoft and MITRE have developed a tool that works like an automated adversarial attack library for those that lack a deep background in machine learning or artificial intelligence, providing insights on how these attacks…
Continue Reading
Gene therapy for hemophilia A patients in the U.S. will have to wait. The FDA needs more time to review data from BioMarin Pharmaceuticals, and the agency told the company it won’t be able…
Continue Reading
As we dive right into 2023, medical affairs teams are at a turning point.
MSLs are no longer wasting valuable time waiting in line within the halls of ivory towers, trying to get face-time or…
Adaptimmune and TCR2 Therapeutics, two clinical-stage biotechs that have recently cut staff to conserve capital, are coming together in a deal that aligns their cell therapy strategies. The business combination also extends the new…
Continue Reading
Guilherme Macagnan, CEO, AMX HealthcareThe market demand for data-driven technology solutions in healthcare is on the rise. Today, one-third of the world’s data is generated by the healthcare industry. This data is often complex and is coming from multiple different sources such as personal health information, claims data, clinical trial data,…
Continue Reading
The FDA has accepted Eisai’s application seeking full approval for its Alzheimer’s disease drug, setting a summer date for a regulatory decision that could smooth the path for insurance companies to begin coverage for…
Continue Reading
Chroma Medicine, a biotech company developing therapies that turn genes on or off as a way of treating genetic disorders, has raised $135 million as it works to generate data that could show the…
Continue Reading
